These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 37764023)

  • 1. Interferons-Implications in the Immune Response to Respiratory Viruses.
    Bergeron HC; Hansen MR; Tripp RA
    Microorganisms; 2023 Aug; 11(9):. PubMed ID: 37764023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons.
    Czerkies M; Kochańczyk M; Korwek Z; Prus W; Lipniacki T
    J Virol; 2022 Nov; 96(22):e0134122. PubMed ID: 36326278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection.
    Li M; Ayyanathan K; Dittmar M; Miller J; Tapescu I; Lee JS; McGrath ME; Xue Y; Vashee S; Schultz DC; Frieman MB; Cherry S
    mBio; 2023 Aug; 14(4):e0119423. PubMed ID: 37377442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies.
    Schijf MA; Lukens MV; Kruijsen D; van Uden NO; Garssen J; Coenjaerts FE; Van't Land B; van Bleek GM
    PLoS One; 2013; 8(11):e81695. PubMed ID: 24303065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus.
    Ascough S; Paterson S; Chiu C
    Front Immunol; 2018; 9():323. PubMed ID: 29552008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity of extracellular vesicles derived from respiratory syncytial virus-infected airway epithelial cells.
    Corsello T; Qu Y; Ivanciuc T; Garofalo RP; Casola A
    Front Immunol; 2022; 13():886701. PubMed ID: 36032066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferons as negative regulators of ILC2s in allergic lung inflammation and respiratory viral infections.
    Wang C; Du Z; Li R; Luo Y; Zhu C; Ding N; Lei A
    J Mol Med (Berl); 2023 Aug; 101(8):947-959. PubMed ID: 37414870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.
    Yun J; Park JH; Kim N; Roh EY; Shin S; Yoon JH; Kim TS; Park H
    J Korean Med Sci; 2021 Dec; 36(48):e328. PubMed ID: 34904407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection.
    Goritzka M; Durant LR; Pereira C; Salek-Ardakani S; Openshaw PJ; Johansson C
    J Virol; 2014 Jun; 88(11):6128-36. PubMed ID: 24648449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection.
    Cormier SA; Shrestha B; Saravia J; Lee GI; Shen L; DeVincenzo JP; Kim YI; You D
    J Virol; 2014 Aug; 88(16):9350-60. PubMed ID: 24920801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection.
    Descamps D; Peres de Oliveira A; Gonnin L; Madrières S; Fix J; Drajac C; Marquant Q; Bouguyon E; Pietralunga V; Iha H; Morais Ventura A; Tangy F; Vidalain PO; Eléouët JF; Galloux M
    J Virol; 2021 Oct; 95(22):e0091221. PubMed ID: 34431698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in innate anti-viral immune responses to respiratory viruses and in their clinical outcomes in a birth cohort study.
    Regis E; Fontanella S; Lin L; Howard R; Haider S; Curtin JA; Edwards MR; Rattray M; Simpson A; Custovic A; Johnston SL
    Sci Rep; 2021 Dec; 11(1):23741. PubMed ID: 34887467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity.
    Hijano DR; Vu LD; Kauvar LM; Tripp RA; Polack FP; Cormier SA
    Front Immunol; 2019; 10():566. PubMed ID: 30972063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral co-infection with human respiratory syncytial virus in suspected acute and severe respiratory tract infections during COVID-19 pandemic in Yaoundé, Cameroon, 2020-2021.
    Moumbeket Yifomnjou MH; Monamele GC; Njankouo-Ripa M; Fatawou Modiyinji A; Ngoupo PA; Boyomo O; Njouom R
    Influenza Other Respir Viruses; 2023 Mar; 17(3):e13131. PubMed ID: 36991539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid differential diagnosis of SARS-CoV-2, influenza A/B and respiratory syncytial viruses: Validation of a novel RT-PCR assay.
    Domnich A; Bruzzone B; Trombetta CS; De Pace V; Ricucci V; Varesano S; Garzillo G; Ogliastro M; Orsi A; Icardi G
    J Clin Virol; 2023 Apr; 161():105402. PubMed ID: 36805601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma.
    Patel DA; You Y; Huang G; Byers DE; Kim HJ; Agapov E; Moore ML; Peebles RS; Castro M; Sumino K; Shifren A; Brody SL; Holtzman MJ
    J Allergy Clin Immunol; 2014 Dec; 134(6):1402-1412.e7. PubMed ID: 25216987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Human Nose Organoid Respiratory Virus Model: an
    Rajan A; Weaver AM; Aloisio GM; Jelinski J; Johnson HL; Venable SF; McBride T; Aideyan L; Piedra FA; Ye X; Melicoff-Portillo E; Yerramilli MRK; Zeng XL; Mancini MA; Stossi F; Maresso AW; Kotkar SA; Estes MK; Blutt S; Avadhanula V; Piedra PA
    mBio; 2021 Feb; 13(1):e0351121. PubMed ID: 35164569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?
    Sacchi A; Giannessi F; Sabatini A; Percario ZA; Affabris E
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.